The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis

Virology

Volumn 245, Issue 2, 1998, Pages 270-280

  Lin, Mark T ^a   Hinton, David R ^a,b   Parra, Beatriz ^b   Stohlman, Stephen A ^b   Van Der Veen, Roel C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; DEMYELINATING DISEASE; HEPATITIS VIRUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS ENCEPHALITIS; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALIA; MURINE HEPATITIS VIRUS; RNA VIRUSES;

EID: 0032486280     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9170     Document Type: Article

References (57)

1. Adami C., Pooley J., Glomb J., Stecker E., Fazal F., Fleming J. O., Baker S. C. Evolution of mouse hepatitis virus (MHV) during chronic infection: Quasispecies nature of the persisting MHV RNA. Virology. 209:1995;337-346.
2. Berg D. J., Leach M. W., Kuhn R., Rajewsky K., Muller W., Davidson N. J., Rennick D. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J. Exp. Med. 182:1995;99-108.
3. Biron C. A. Cytokines in the generation of immune rsponses to, and resolution of, virus infection. Curr. Opin. Immunol. 6:1994;530-538.
4. Brown M., Hural J. Functions of IL-4 and control of its expression. Crit. Rev. Immunol. 17:1997;1-32.
5. Campbell I. L., Samimi A., Chiang C. S. Expression of the inducible nitric oxide synthase: Correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis. J. Immunol. 153:1994;3622-3629.
6. Chao C. C., Molitor T. W., Hu S. Neuroprotective role of IL-4 against activated microglia. J. Immunol. 151:1993;1473-1481.
7. Chen W. F., Zlotnik A. IL-10: A novel cytotoxic T cell differentiation factor. J. Immunol. 147:1991;528-534.
8. Cua D. J., Hinton D. R., Stohlman S. A. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice: Th2-mediated suppression of autoimmune disease. J. Immunol. 155:1995;4052-4059.
9. Dai W. J., Kohler G., Brombacher F. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J. Immunol. 158:1997;2259-2267.
10. Dorries R., Schwender S., Imrich H., Harms H. Population dynamics of lymphocyte subsets in the central nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis. Immunology. 74:1991;539-545.
11. Finke D., Brinckmann U. G., ter Meulen V., Liebert U. G. Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J. Virol. 69:1995;5469-5474.
12. Fleming J. O., Shubin R. A., Sussman M. A., Casteel N., Stohlman S. A. Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology. 168:1988;162-167.
13. Fleming J. O., Stohlman S. A., Harmon R. C., Lai M. M., Frelinger J. A., Weiner L. P. Antigenic relationships of murine coronaviruses: Analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology. 131:1983;296-307.
14. Fleming J. O., Trousdale M., El-Zaatari F., Stohlman S. A., Weiner L. P. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 58:1986;869-875.
15. Gallo P., Sivieri S., Rinaldi L., Yan X. B., Lolli F., De Rossi A., Tavolato B. Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system. J. Neurol. Sci. 126:1994;49-53.
16. Gazzinelli R. T., Wysocka M., Hieny S., Scharton Kersten T., Cheever A., Kuhn R., Muller W., Trinchieri G., Sher A. In the absence of endogenous IL-10, mice acutely infected withToxoplasma gondii. J. Immunol. 157:1996;798-805.
17. Grzybicki D. M., Kwack K., Perlman S., Murphy S. P. Nitric oxide synthase Type II expression by different cell types in MHC-JHM encephalitis suggests distinct roles for nitric oxide in acute versus persistent virus infection. J. Neuroimmunol. 73:1997;15-27.
18. Hooper D. C., Ohnishi S. T., Kean R., Numagami Y., Dietzschold B., Koprowski H. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. USA. 92:1995;5312-5316.
19. Houtman J. J., Fleming J. O. Pathogenesis of mouse hepatitis virus-induced demyelination. J. Neurovirol. 2:1996;361-376.
20. Hunter C. A., Ellis Neyes L. A., Slifer T., Kanaly S., Grunig G., Fort M., Rennick D., Araujo F. G. Trypanosoma cruzi. J. Immunol. 158:1997;3311-3316.
21. Irani D. N., Lin K. I., Griffin D. E. Regulation of brain-derived T cells during acute central nervous system inflammation. J. Immunol. 158:1997;2318-2326.
22. Issazadeh S., Lorentzen J. C., Mustafa M. I., Hojeberg B., Mussener A., Olsson T. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: Persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta. J. Neuroimmunol. 69:1996;103-115.
23. Kennedy M. K., Torrance D. S., Picha K. S., Mohler K. M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:1992;2496-2505.
24. Korner H., Schliephake A., Winter J., Zimprich F., Lassmann H., Sedgwick J., Siddell S., Wege H. Nucleocapsid or spike protein-specific CD4+ T lymphocytes protect against coronavirus-induced encephalomyelitis in the absence of CD8+ T cells. J. Immunol. 147:1991;2317-2323.
25. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:1993;263-274.
26. Kurilla M. G., Swaminathan S., Welsh R. M., Kieff E., Brutkiewicz R. R. Effects of virally expressed interleukin-10 on vaccinia virus infection in mice. J. Virol. 67:1993;7623-7628.
27. Kyuwa S., Stohlman S. A. Pathogenesis of neurotropic murine coronavirus strain JHM in the central nervous system. Semin. Virol. 1:1990;273-280.
28. Lane T. E., Buchmeier M. J. Murine coronavirus infection: A paradigm for virus-induced demyelinating disease. Trends Microbiol. 5:1997;9-14.
29. Lane T. E., Paoletti A. D., Buchmeier M. J. Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus. J. Virol. 71:1997;2202-2210.
30. Lin M. T., Stohlman S. A., Hinton D. R. Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J. Virol. 71:1997;383-391.
31. Moore K. W., A O. G., de Waal Malefyt R., Vieira P., Mosmann T. R. Interleukin-10. Annu. Rev. Immunol. 11:1993;165-190.
32. Moran T. M., Isobe H., Fernandez Sesma A., Schulman J. L. Interleukin-4 causes delayed virus clearance in influenza virus-infected mice. J. Virol. 70:1996;5230-5235.
33. Mustafa M. M., Lebel M. H., Ramilo O., Olsen K. D., Reisch J. S., Beutler B., McCracken G. H. Jr. Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J. Pediatr. 115:1989;208-213.
34. Navikas V., Link H. Review: Cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45:1996;322-333.
35. Parra B., Hinton D. R., Lin M. T., Cua D. J., Stohlman S. A. Kinetics of cytokine mRNA expression in the central nervous system following lethal and nonlethal coronavirus-induced acute encephalomyelitis. Virology. 233:1997;260-270.
36. Perlman S., Ries D. The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM. Microbial Pathogenesis. 3:1987;309-314.
37. Powrie F., Menon S., Coffman R. L. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 23:1993;3043-3049.
38. Racke M. K., Burnett D., Pak S. H., Albert P. S., Cannella B., Raine C. S., McFarlin D. E., Scott D. E. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J. Immunol. 154:1995;450-458.
39. Rott O., Fleischer B., Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1994;1434-1440.
40. Ruddle N. H., Bergman C. M., McGrath K. M., Lingenheld E. G., Grunnet M. L., Padula S. J., Clark R. B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1990;1193-1200.
41. Selmaj K. W., Raine C. S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:1988;339-346.
42. Shaw M. K., Lorens J. B., Dhawan A., DalCanto R., Tse H. Y., Tran A. B., Bonpane C., Eswaran S. L., Brocke S., Sarvetnick N., Steinman L., Nolan G. P., Fathman C. G. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1997;1711-1714.
43. Schluter D., Kaefer N., Hof H., Wiestler O. D., Deckert-Schluter M. Expression pattern and cellular origin of cytokines in the normal andToxoplasma gondii. Am. J. Pathol. 150:1997;1021-1035.
44. Stohlman S. A., Bergmann C. C., van der Veen R. C., Hinton D. R. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J. Virol. 69:1995a;684-694.
45. Stohlman S. A., Hinton D. R., Cua D., Dimacali E., Sensintaffar J., Hofman F. M., Tahara S. M., Yao Q. Tumor necrosis factor expression during mouse hepatitis virus-induced demyelinating encephalomyelitis. J. Virol. 69:1995b;5898-5903.
46. Stohlman S. A., Matsushima G. K., Casteel N., Weiner L. P. In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication. J. Immunol. 136:1986;3052-3056.
47. Sun N., Grzybicki D., Castro R. F., Murphy S., Perlman S. Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology. 213:1995;482-493.
48. Tonnetti L., Spaccapelo R., Cenci E., Mencacci A., Puccetti P., Coffman R. L., Bistoni F., Romani L. Interleukin-4 and -10 exacerbate candidiasis in mice. Eur. J. Immunol. 25:1995;1559-1565.
49. Tucker P. C., Griffin D. E., Choi S., Bui N., Wesselingh S. Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis. J. Virol. 70:1996;3972-3977.
50. Weiner L. P. Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus). Acta Neurol. 18:1973;298-303.
51. Welsh R. M., Selin L. K., Razvi E. S. Role of apoptosis in the regulation of virus-induced T cell responses, immune suppression, and memory. J. Cell Biochem. 59:1995;135-142.
52. Widmer M. B., Grabstein K. H. Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor. Nature (London). 326:1987;795-798.
53. Willenborg D. O., Fordham S., Bernard C. C., Cowden W. B., Ramshaw I. A. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:1996;3223-3227.
54. Williamson J. Virus-specific T cells in the central nervous system following infection iwth an avirulent neurotropic mouse hepatitis virus. Regional Immunol. 4:1992;145-152.
55. Williamson J. S., Stohlman S. A. Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J. Virol. 64:1990;4589-4592.
56. Williamson J. S., Sykes K. C., Stohlman S. A. Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J. Neuroimmunol. 32:1991;199-207.
57. Yamaguchi K., Goto N., Kyuwa S., Hayami M., Toyoda Y. Protection of mice from a lethal coronavirus infection in the central nervous system by adoptive transfer of virus-specific T cell clones. J. Neuroimmunol. 32:1991;1-9.